Aditxt

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Aditxt and other ETFs, options, and stocks.

About ADTX

Aditxt, Inc. is a biotech innovation company, which engages in the development and commercialization of technologies focusing on monitoring and modulating the immune system. Its innovation portfolio includes Adimune and AditxtScore. 

CEO
Amro Albanna
CEOAmro Albanna
Employees
26
Employees26
Headquarters
Mountain View, California
HeadquartersMountain View, California
Founded
2017
Founded2017
Employees
26
Employees26

ADTX Key Statistics

Market cap
1.63M
Market cap1.63M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
3.18M
Average volume3.18M
High today
$3.01
High today$3.01
Low today
$2.65
Low today$2.65
Open price
$2.80
Open price$2.80
Volume
348.19K
Volume348.19K
52 Week high
$10,311.25
52 Week high$10,311.25
52 Week low
$2.36
52 Week low$2.36

Stock Snapshot

The current Aditxt(ADTX) stock price is $2.91, with a market capitalization of 1.63M.

On 2025-12-04, Aditxt(ADTX) stock traded between a low of $2.65 and a high of $3.01. Shares are currently priced at $2.91, which is +9.8% above the low and -3.3% below the high.

The Aditxt(ADTX)'s current trading volume is 348.19K, compared to an average daily volume of 3.18M.

In the last year, Aditxt(ADTX) shares hit a 52-week high of $10,311.25 and a 52-week low of $2.36.

In the last year, Aditxt(ADTX) shares hit a 52-week high of $10,311.25 and a 52-week low of $2.36.

People also own

Based on the portfolios of people who own ADTX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.